Wormwood Pollen Allergy: Mugwort's Art v 1 and Fall Celery-Spice Syndrome

Art v 1 is the major allergen of Artemisia vulgaris (mugwort/wormwood) pollen — a defensin-like polyproline-linked protein recognized by 95 percent or more of genuinely sensitized patients. It is classified as the mugwort-specific diagnostic marker because it has no close structural homolog in ragweed pollen (Amb a 1 is ragweed's marker) or other major weed pollens. Measuring Art v 1-specific IgE distinguishes true mugwort primary sensitization from cross-reactive positivity due to pan-allergens (profilins, polcalcins) or pectate lyase cross-reactivity with ragweed. This distinction matters clinically: only patients with genuine Art v 1 sensitization reliably benefit from Artemisia-targeted immunotherapy, while cross-reactive positivity without Art v 1 may not warrant Artemisia SLIT specifically.

The celery-mugwort-spice syndrome is a documented food cross-reactivity pattern in Artemisia-sensitized patients where IgE antibodies generated against Art v 1 and Art v 4 (profilin) cross-react with proteins in celery, carrot, fennel, coriander, cumin, and anise. The newly characterized celery allergen Api g 7 is a defensin-like protein showing 0.86 IgE correlation with Art v 1, explaining why mugwort-allergic patients so often react to celery. Symptoms typically include oral allergy syndrome (oral tingling, lip swelling) after eating raw celery or spiced dishes, most commonly during or shortly after fall Artemisia pollen season when mucosal sensitization is highest. Cooking generally denatures the cross-reactive proteins — cooked celery and spices in hot dishes are usually better tolerated than raw preparations.

Sagebrush and mugwort are both Artemisia species and share the WHO/IUIS allergen family — Art v 1, Art v 3, and related proteins are present across multiple Artemisia species with high sequence identity. A. vulgaris (mugwort) dominates eastern US and European populations; A. tridentata (big sagebrush) dominates western US populations; A. absinthium (absinthe wormwood) is present in both. In clinical practice, cross-species IgE reactivity within Artemisia is extensive, and patients sensitized to one species are almost certainly cross-reactive with others. Immunotherapy using A. vulgaris extract addresses the full Artemisia family cross-reactive panel, including sagebrush sensitization in western US patients.

Yes — wormwood/mugwort pollen allergy is one of the most clinically important pollen-food syndrome sources. Two distinct food cross-reactivity pathways are documented. Art v 1/Art v 4 cross-reactivity drives the celery-mugwort-spice syndrome: reactions to raw celery, carrot, coriander, cumin, fennel, and anise. Art v 3 (nsLTP) cross-reactivity drives the mugwort-peach association: reactions to peach, stone fruits, and other LTP-containing foods; in Art v 3-positive patients, reactions can be systemic and include anaphylaxis. A board-certified allergist should measure Art v 1 and Art v 3 component IgE in any mugwort-allergic patient who reports food reactions to understand which pathway is responsible and what dietary management and emergency preparedness are appropriate.

Both wormwood (Artemisia) and ragweed (Ambrosia) are major fall weed pollen allergens with overlapping August through October seasons, causing nearly identical respiratory symptoms. The key differences: Artemisia dominates western US (sagebrush steppe) and Europe; ragweed dominates eastern US. Component-resolved diagnostics with Art v 1 (mugwort marker) versus Amb a 1 (ragweed marker) are essential to identify the primary sensitizer — cross-reactivity between the two species via pectate lyases (Art v 6 and Amb a 1) means standard SPT or total extract IgE testing can produce misleading cross-positive results. The food cross-reactivity profiles are completely different: mugwort drives celery-spice syndrome and mugwort-peach LTP association; ragweed drives cucumber/melon oral allergy syndrome via Amb a 1/profilin.

Usually yes — the celery-mugwort-spice syndrome is driven by Art v 1 and Art v 4 (profilin) cross-reactive proteins that are generally heat-labile, meaning cooking at typical culinary temperatures denatures the cross-reactive epitopes and renders cooked celery, cooked carrots, and spices in hot dishes much better tolerated than raw preparations. Most patients with the celery-mugwort-spice syndrome can tolerate cooked celery in soups, stir-fries, and casseroles while reacting to raw celery sticks, fresh coriander leaves, and raw carrot. However, this is not absolute — highly sensitized individuals may react even to cooked preparations. Art v 3 (nsLTP)-mediated peach reactions are different: nsLTPs are heat-stable, and cooking does not reliably destroy their allergenicity.

Yes — sublingual immunotherapy (SLIT) is directly indicated for Art v 1-confirmed Artemisia pollen allergy and is among the most evidence-supported SLIT indications for weed pollen allergens. Multiple randomized controlled trials demonstrate 60 to 80 percent reduction in fall rhinitis symptom scores over a 3 to 5-year SLIT course for Artemisia-allergic patients. The at-home administration of SLIT drops eliminates the weekly clinic visits required for allergy shots, which is especially practical for managing the 8 to 10-week sustained Artemisia season and for patients whose schedule makes weekly clinic attendance difficult. Component-resolved diagnosis confirming Art v 1 positivity prior to starting SLIT ensures that treatment is targeted at genuine mugwort sensitization rather than pan-allergen cross-reactivity.

The mugwort-peach association is a clinically important pollen-food syndrome where Artemisia Art v 3 (nsLTP) cross-reacts with peach Pru p 3 (nsLTP) and related lipid transfer proteins in other stone fruits. Unlike the celery-mugwort-spice syndrome (where cooking usually destroys the allergen), nsLTP proteins are heat-stable and digestion-resistant — meaning cooked peach, peach jam, dried peach, and processed products can still cause reactions in Art v 3-positive patients. In Chinese cohort data, 72 percent of mugwort-allergic patients have food allergy, and 48 percent experience food-induced anaphylaxis correlating with Art v 3. Art v 3 testing is essential for any mugwort-allergic patient with peach, stone fruit, or unexplained food reactions — positive results warrant epinephrine auto-injector prescription.

You should see a board-certified allergist if you have recurring fall respiratory symptoms (August through October) that significantly impair daily function, work, or sleep; if you have asthma that consistently worsens in fall; if you develop oral or systemic reactions after eating celery, spices, or peach in association with fall pollen season; or if standard over-the-counter antihistamines and nasal sprays provide inadequate symptom control. An allergist can confirm Artemisia sensitization through SPT and Art v 1/Art v 3 component testing, establish your food cross-reactivity risk profile, prescribe appropriate pharmacotherapy, and evaluate your candidacy for allergen-specific immunotherapy. Seek emergency care immediately if you experience throat tightness, difficulty breathing, or lightheadedness after food ingestion — these may indicate anaphylaxis.

Yes — a patient can simultaneously have IgE-mediated wormwood pollen allergy (Art v 1-driven fall rhinitis, celery-spice syndrome) and Type IV contact allergy from wormwood plant sesquiterpene lactones (artabsin, absinthin), which causes skin dermatitis when handling wormwood plants or Artemisia-containing herbal preparations. These are mechanistically completely distinct conditions: one is antibody-mediated (IgE, immediate), the other is T-cell-mediated (delayed, 24 to 96 hours). Allergen immunotherapy addresses the IgE pollen component only — it has no effect on the Type IV contact sensitization. The wormwood contact allergy page covers that separate mechanism in detail. Patients with both conditions benefit from keeping the two management pathways clearly distinguished with their allergist and dermatologist.